Activation of the EGFR signaling pathway results in increased tumor proliferation, angiogenesis, metastasis, and tumor invasiveness through the binding of a number of different ligands, including EGF-like molecules, transforming growth factor-α (TGFα), and neuregulins to the receptor’s ectodomain [3]. Here, EGFR is linked to neoplasm.